AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05461092 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Saint Louis University Mental Status Examination (SLUMs)
Description: Questionnaire assessing baseline cognition.
Study NCT05461092 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Saint Louis University Mental Status Examination (SLUMs)
Description: Questionnaire assessing baseline cognition.
Study NCT05461092 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Delirium Rating Scale-Revised-98 (DRS)
Description: 16 item clinician rated scale assessing delirium severity.
Study NCT04956744 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IMS001
Description: IMS001 is a human embryonic cell derived (hESC) mesenchymal stem cell (MSC).
Study NCT05261087 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: Individuals will not receive any interventions
Study NCT04965038 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Alteplase
Description: Intravenous thrombolysis with alteplase within 4.5 hours of symptom onset
Study NCT06233175 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: combined kinetic chain exercises
Description: combined kinetic chain exercises in form of wall slide ,terminal knee extension ,forward step up and down ,side step up and down ,straight leg raise ,seated knee extension ,stretching exercises , hot back and trans cutaneous electrical stimulation,
Study NCT06233175 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional
Description: stretching exercises and hot back and trans cutaneous electrical stimulation,with out combined kinetic chain exercises
Study NCT04965038 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alteplase
Description: Intravenous thrombolysis with alteplase within 4.5 hours of symptom onset
Study NCT05461092 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Delirium Rating Scale-Revised-98 (DRS)
Description: 16 item clinician rated scale assessing delirium severity.
Study NCT05461092 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telephone Interview for Cognitive Status - Modified (TICS-M)
Description: Telephone interview questionnaire evaluating patient cognitive status.
Study NCT05461092 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Telephone Interview for Cognitive Status - Modified (TICS-M)
Description: Telephone interview questionnaire evaluating patient cognitive status.
Study NCT05461092 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Opioid Equivalents measured by Morphine Milligram Equivalents (MME)
Description: The amount of opioids administered will be collected through patient self-report
Study NCT01710865 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ultraseal Sealant
Description: This is a newly developed hydrophilic sealant material.
Study NCT01710865 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ultraseal Sealant
Description: This is a previously existing hydrophobic sealant material.
Study NCT05461092 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Opioid Equivalents measured by Morphine Milligram Equivalents (MME)
Description: The amount of opioids administered will be collected through patient self-report
Study NCT05461092 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patient Health Questionnaire depression scale (PHQ-8)
Description: Questionnaire used to diagnose and determine the severity measure for depressive disorders.
Study NCT05461092 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Patient Health Questionnaire depression scale (PHQ-8)
Description: Questionnaire used to diagnose and determine the severity measure for depressive disorders.
Study NCT05461092 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pain Catastrophizing
Description: Scale used to determine pain catastrophizing and it's severity.
Study NCT05461092 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pain Catastrophizing
Description: Scale used to determine pain catastrophizing and it's severity.
Study NCT06528327 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pre coated impants
Description: Pre coated impants with microstructured bioactive antimicrobial coating with double threading for higher bone-to-implant contact and faster bone gathering on the surface.
Study NCT06528327 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Non coated implant surface
Description: Non-coated implant with double threading for higher bone-to-implant contact and faster bone gathering on the surface.
Study NCT05760482 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Metobolites serum level measurement
Description: Blood samples will be taken from all volunteer participants in 1 yellow cap tube of 10 cc. After the blood has cooled and the clot development process (approximately 15 minutes), the serum will be separated by centrifugation at 2000 g for 5 minutes. Separated sera will be aliquoted and stored at -40°C until analysis. The tryptophan and tryptophane metabolite levels of the participants will be measured by Liquid Chromatography-Tandem Mass Spectrometer API 3200 device. The kynurenine, kynurenic acid, 3-HK, 3-HAA, 3-HOA, and QA values obtained as a result of this test will be recorded.
Study NCT05760482 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Anxiety and stress level measurement
Description: Anxiety and stress levels will be evaluated by applying State-Trait Anxiety Inventory and Perceived Stress Scale Tests by all volunteer participants. Scores from these tests will be recorded.
Study NCT05483426 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: semi-structured Interviews
Description: semi-structured interview conducted by a psychiatrist
Study NCT06512662 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Consultations with paramedics
Description: Patients of experimental arm will beneficiate of supplemental consultations with paramedics intervenants at 1 month, 3 months and 6 months after surgery :~* dietetician~* speech therapist~* psychologist~* advanced practice nurse~During these consultations, several scales will be performed to assess the patient's condition (anxiety, nutritional status, psychological condition, speech therapy status).
Study NCT06567509 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core stability exercises and Short foot exercises
Description: Core stabilty exercises are the exercises where subjects will be trained to perform exercises like: Curl ups, bridging, side bridges, Planks, and Quadripedal stance exercises in a phased manner, each phase lasting 2 weeks. Complexities and duration of exercises will be increased in each phase. Short foot exercises for control group will include traditional treatment of stretching and strengthening of foot musculature.
Study NCT06567509 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Conventional foot exercises and short foot exercises
Description: Ankle dorsiflexion, Plantar flexion, Inversion and Eversion range of motion exercises
Study NCT05461092 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fear Avoidance Beliefs Questionnaire (FABQ)
Description: Questionnaire used to help predict patients that have a high pain avoidance behavior.
Study NCT05461092 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fear Avoidance Beliefs Questionnaire (FABQ)
Description: Questionnaire used to help predict patients that have a high pain avoidance behavior.
Study NCT05461092 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Opioid Side Effects and Likeability Questionnaire
Description: Survey determining adverse events related to opioid side effects and complications.
Study NCT05461092 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Opioid Side Effects and Likeability Questionnaire
Description: Survey determining adverse events related to opioid side effects and complications.
Study NCT05461092 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Daily Pain Trajectory
Description: Questionnaire assessing pain location, severity, impact to quality of life, and medications used to alleviate.
Study NCT02840214 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: transcranial direct current stimulation
Description: Soterix tDCS RCT device given over left DLPFC for 20 minutes at 2mA.
Study NCT02840214 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: sham tDCS
Description: Soterix tDCS RCT device given over left DLPFC with 30 second ramp on and off of current
Study NCT06684613 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PrEP Decision Aid
Description: Patient-facing decision-aid on PrEP that is already gender- and trauma- responsive and will be enhanced to include various formulations of available PrEP. Can be integrated into sexual and reproductive health clinics as part of contraceptive counseling.
Study NCT06684613 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Generic Information
Description: Participants will be asked to watch a CDC-produced video, PrEP (Pre-Exposure Prophylaxis (available online free of charge through the CDC web site). The video will serve as a time- and attention- based control to the decision aid.
Study NCT06701981 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Filter comparison
Description: Three filters will be compared on light discomfort thresholds using the Lumiz 100™ device
Study NCT06700954 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: legume-rich Planetary Health Diet
Description: legume-rich diet based on the Planetary Health Diet, with a focus on vegetable protein
Study NCT06700954 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: control diet based on Western Diet low in legumes
Description: diet based on the Western dietary pattern including animal protein sources (= control diet)
Study NCT06703476 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Stent placement
Description: Surgeon may choose to use a single or double J ureteral stent (6- to 8.5-fr in size) or an alternative ureteral stent of the surgeon's choice.
Study NCT06703476 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alvimopan
Description: Patient will receive alvimopan as a fixed 12-mg dose, with the first dose administered 0.5 to 5 h before the start of surgery; administration will be continued with twice daily oral doses postoperatively until hospital discharge or a maximum of 7 days (15 in-hospital doses).
Study NCT06703112 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: An auxiliary diagnostic model for ovarian tumors
Description: Through collaboration among gynecological oncology teams from three research centers, the multimodal ovarian tumor auxiliary diagnosis system will undergo multicenter, prospective clinical application, with surgical pathology results used as the gold standard. The diagnostic performance of the multimodal ovarian tumor auxiliary diagnosis system, both overall and across different pathological categories, will be evaluated in the main and subsidiary centers by comparing metrics such as specificity, sensitivity, positive predictive value, negative predictive value, and area under the ROC curve (AUC).
Study NCT03910010 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebos
Description: Positive treatment expectations will be induced by giving participants capsules containing inert material and telling them that the capsules contain an effective drug that has been approved for treating Chronic Pain. They will be requested to take two capsules four times a day and report their pain on paper forms organized as a calendar or on REDCap.
Study NCT05385744 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BCD-132
Description: anti-CD20 monoclonal antibody
Study NCT05385744 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Teriflunomide
Description: Teriflunomide 14 mg
Study NCT05166421 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AZD7442
Description: AZD7442 will be administered via IM route.
Study NCT05166421 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: AZD8895 (clonal cell line material)
Description: AZD8895 will be administered via IM route.
Study NCT05166421 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: AZD1061 (clonal cell line material)
Description: AZD1061 will be administered via IM route.
Study NCT05166421 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: AZD8895 (cell pool material)
Description: AZD8895 will be administered via IM route.
Study NCT05166421 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: AZD1061 (cell pool material)
Description: AZD1061 will be administered via IM route.
Study NCT06525155 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Triptorelin Embonate
Description: Treatment 1: 3.75 mg twice before surgery (baseline and week-6) and once after surgery at week-12
Study NCT06525155 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Triptorelin Embonate
Description: Treatment 2: 3.75 mg once after surgery at week-12
Study NCT05408728 — intervention group
Intervention type: PROCEDURE
Intervention: Endoscopic biopsy
Description: Upper small intestinal biopsies from patients undergoing BS will be collected during routine standard of care screening EGD and again from the same patients at 1 year during routine standard of care surveillance EGD (esophageal reflux screening/surveillance). Biopsy-derived enteroid cultures and tissue samples from pre- and one-year post BS will be examined for expression level of sugar transporters and gluconeogenic enzymes; glucose and fructose absorption
Study NCT05940870 — intervention group
Intervention type: DEVICE
Intervention: Nerivio
Description: Patients with migraine who received the Nerivio device for migraine prevention therapy
Study NCT04424407 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Cognitive Behavioral Therapy for Insomnia
Description: Participants will meet with a psychologist once a week for six weeks to complete a brief CBT-I intervention. Cognitive Behavioral Therapy for Insomnia consists of a cognitive therapy and a behavioral therapy. The cognitive therapy is designed to identify incorrect ideas about sleep, challenge their validity, and replace them with correct information. This therapy tries to reduce worry, anxiety, and fear that one won't sleep by providing accurate information about sleep. The behavioral therapy increases sleep quality by limiting excessive time spent in bed to increase homeostatic sleep drive and sleep consolidation.
Study NCT04876859 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: CRF of anterior sensitive branches to the hip
Description: Steroid and anesthetic extra articular injection followed by denervation using CRF at 90 celsius degree during a period 90 minutes at the sensitive branches of obturator and femoral nerve, separately.
Study NCT04876859 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Anesthetic block with steroid injection of anterior sensitive branches to the hip
Description: Corticosteroid and anesthetic extra articular injection at the sensitive branches of obturator and femoral nerve, only
Study NCT05365347 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Enhancement Therapy (CET)
Description: Cognitive enhancement therapy is an evidence based intervention for schizophrenia focused on improving the cognitive domains of memory, attention span and learning ability. It has shown efficacy in reducing substance use as an indirect outcome but this will be the focus of this intervention.
Study NCT06536686 — intervention group
Intervention type: GENETIC
Intervention: Silent myocardial ischemia, STEMI
Description: Silent myocardial ischemia association with genetic polymorphisms, miRNA and EVs
Study NCT03828201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Delamanid
Description: Frequency: daily Route of administration: oral~Delamanid is a medication used to treat tuberculosis. Specifically it is used, along with other antituberculosis medications, for active multidrug-resistant tuberculosis. It is taken by mouth.
Study NCT03828201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levofloxacin
Description: Frequency: daily Route of administration: oral~Levofloxacin is an antibiotic used to treat a number of bacterial infections including acute bacterial sinusitis, pneumonia, urinary tract infections, chronic prostatitis, and some types of gastroenteritis. Along with other antibiotics it may be used to treat tuberculosis.
Study NCT03828201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bedaquiline
Description: Frequency: daily Route of administration: oral~Bedaquiline is indicated for use as part of an appropriate combination regimen for pulmonary multidrug-resistant tuberculosis (MDR-TB) in adult patients when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability.
Study NCT03828201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clofazimine
Description: Frequency: daily Route of administration: oral~Clofazimine has shown activity against multidrug-resistant tuberculosis (MDR-TB) and is now recommended by the World Health Organization (WHO) to treat drug resistant tuberculosis as a Group B drug. It is thought that clofazimine acts by inhibiting the formation of matrixes within the DNA and thus delaying the growth of the bacterium. Clofazimine first received FDA approval in 1986, although its use in the treatment of MDR-TB has not been approved by any stringent regulatory authorities and it is therefore used off-label for this function.
Study NCT03828201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linezolid
Description: Frequency: daily Route of administration: oral~Linezolid is an antibiotic used for the treatment of infections caused by Gram-positive bacteria that are resistant to other antibiotics.
Study NCT04955873 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Treatment of the dental extraction socket using newly-released biomaterials
Description: Treatment of the dental extraction socket with the combined use with the combined use of a newly-released xenogenic bone granules and a resorbable collagen membrane.
Study NCT04955873 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Treatment of the dental extraction socket using well-known biomaterials
Description: Treatment of the dental extraction socket with the combined use of a well-known xenogenic bone granules and a resorbable collagen membrane
Study NCT06567795 — intervention group
Intervention type: DEVICE
Intervention: Hemotag
Description: Hemotag non-invasive medical device is used to see cardiac function for DM2 patients at-home for 30 days
Study NCT06460246 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulse Oximeter
Description: The subjects will have a 22-gauge catheter inserted in the radial artery to measure the oxygen saturation of arterial blood and also wear pulse oximeters.
Study NCT04976387 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydrocodone/Acetaminophen 5 Mg-325 Mg ORAL TABLET
Description: Patients are instructed to take Hydrocodone/acetaminophen 5 mg-325 mg oral tablets every 6 hours as needed for treatment of severe pain
Study NCT04976387 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen 600 mg
Description: Patients will take ibuprofen 600 mg every 6 hours as needed
Study NCT04976387 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetaminophen 650 MG
Description: Patients will take Tylenol 650mg every 6 hours as needed
Study NCT05928078 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: intervention
Description: Participants will be required to use the MOVI-ageing platform 3 times a week for 12 weeks. The platform will include videos of cognitively demanding physical activities designed and guided by health professionals, who will also be able to check compliance with the intervention.
Study NCT06214195 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Shengmai San (ingredients include ginseng, Ophiopogon japonicus, and Schisandra chinensis)
Description: Ginseng 6g , Ophiopogon japonicus 12g ,Schisandra chinensis 5g , other secondary Chinese medicines can be added according to the doctor's judgment and the patient's condition，decoction in water, one dose and two decoctions, taken twice a day, continuously for 7 days from the start of each chemotherapy cycle (± 3 days), including anthracyclines and taxanes (the frequency and dosage of medication can be adjusted according to adverse reactions in the later stage); The total duration of medication interventionis 7 days per cycle, with a total of 8 cycles. If the chemotherapy is less than 8 cycles, continue taking for 7 consecutive days from the start of each subsequent trastuzumab cycle (the frequency and dosage can be adjusted based on adverse reactions) until a total of 8 cycles are reached.
Study NCT05520073 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum
Description: Lactobacillus product 1 pack daily
Study NCT05520073 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin C
Description: Vitamin C tablet 1 pack daily
Study NCT05520073 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Vitamin C
Description: Vitamin C tablet 1 pack daily
Study NCT04868708 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AK104
Description: Subjects will receive AK104 intravenously.
Study NCT04868708 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Subjects will receive Bevacizumab intravenously.
Study NCT04868708 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Subjects will receive Paclitaxel intravenously.
Study NCT04868708 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin or Carboplatin
Description: Subjects will receive Cisplatin or Carboplatin intravenously.